Samsara Bio Capital, LLC Scholar Rock Holding Corp Transaction History
Samsara Bio Capital, LLC
- $217 Million
- Q1 2025
A detailed history of Samsara Bio Capital, LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 5,612,896 shares of SRRK stock, worth $189 Million. This represents 83.28% of its overall portfolio holdings.
Number of Shares
5,612,896
Previous 5,612,896
-0.0%
Holding current value
$189 Million
Previous $243 Million
25.61%
% of portfolio
83.28%
Previous 74.36%
Shares
5 transactions
Others Institutions Holding SRRK
# of Institutions
251Shares Held
89.8MCall Options Held
706KPut Options Held
456K-
Siren, L.L.C. New York, NY9.25MShares$312 Million16.93% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.89MShares$300 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$191 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.85MShares$163 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.4MShares$148 Million14.86% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $1.74B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...